Montanaro Asset Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-133,000
Closed -$10.7M 48
2022
Q3
$10.7M Buy
133,000
+13,000
+11% +$1.1M 1.64% 26
2022
Q2
$8.94M Sell
120,000
-38,000
-24% -$3.47M 1.34% 26
2022
Q1
$20.2M Sell
158,000
-96,000
-38% -$10.5M 2.49% 16
2021
Q4
$34.1M Buy
254,000
+20,000
+9% +$2.87M 3.44% 14
2021
Q3
$32M Sell
234,000
-12,000
-5% -$1.51M 3.86% 9
2021
Q2
$26.3M Buy
246,000
+54,000
+28% +$5.19M 3.3% 12
2021
Q1
$17.3M Buy
+192,000
New +$18M 2.54% 17

Other funds holding DXCM

Montanaro Asset Management's DXCM Position: Q4 2022 in Review

Montanaro Asset Management sold out of DexCom (DXCM) in Q4 2022, closing a stake of 133,000 shares — an estimated $10.7M sold.

Montanaro Asset Management first reported a position in DXCM in Q1 2021 and held it in 7 quarters. The position peaked at $34.1M in Q4 2021. 920 funds tracked by Wall St. Rank hold DXCM as of Q4 2022.

  • Montanaro Asset Management reported no remaining DexCom position as of Q4 2022 after selling out during the quarter.
  • Montanaro Asset Management sold 133,000 DexCom shares in Q4 2022, an estimated $10.7M.
  • Montanaro Asset Management first reported a position in DexCom in Q1 2021 and held it in 7 quarters.
  • Montanaro Asset Management's DexCom position peaked at $34.1M in Q4 2021.
  • 920 funds tracked by Wall St. Rank held DexCom as of Q4 2022.

Based on Montanaro Asset Management's 13F filing for Q4 2022, filed 8 Feb 2023.